Related Experiment Videos
Teicoplanin-induced vasculitis with cutaneous and renal involvement
S A E Logan1, M Brown, R N Davidson
1Department of Infection and Tropical Medicine, Northwick Park Hospital, Harrow, Middlesex HA5 3UJ, UK.
The Journal of Infection
|October 19, 2005
Summary
A patient developed cutaneous vasculitis and kidney problems while being treated with teicoplanin for a hip infection caused by Staphylococcus aureus.
Area of Science:
- Nephrology
- Rheumatology
- Infectious Diseases
Background:
- Teicoplanin is an antibiotic used for serious Staphylococcus aureus infections.
- Osteomyelitis is a bone infection, often requiring long-term antibiotic treatment.
- Cutaneous vasculitis is inflammation of skin blood vessels.
Observation:
- A patient with Staphylococcus aureus osteomyelitis of the hip was treated with teicoplanin.
- The patient subsequently developed symptoms of cutaneous vasculitis.
- Renal impairment was also noted during the course of treatment.
Findings:
- The case suggests a potential link between teicoplanin therapy and the development of cutaneous vasculitis with renal impairment.
- This adverse drug reaction highlights the importance of monitoring kidney function and skin during teicoplanin treatment.
- Differential diagnosis should consider drug-induced vasculitis in patients on teicoplanin.
Implications:
- Clinicians should be vigilant for cutaneous vasculitis and renal impairment in patients receiving teicoplanin.
- This case underscores the need for careful patient monitoring during antibiotic therapy.
- Further investigation may be warranted to elucidate the mechanism of teicoplanin-induced vasculitis.